速递|安进下调GLP-1药物III期研究剂量:降低剂量以限制副作用

GLP1减重宝典
Jun 25, 2025

整理 | GLP1减重宝典内容团队根据周一公布的一项新的中期试验结果,安进公司实验性肥胖症治疗药物MariTide必须从低剂量开始治疗,以减少呕吐等副作用。该研究结果在一次医学会议上公布,导致安进公司股价下跌近6%。为了提高患者的耐受性,安进公司宣布,其正在进行的72周III期试验将把超重或肥胖的受试者分配到三种给药方案中的一种。每组都将从较低的起始剂量开始治疗,并在八周内逐渐增加剂量。安进公司...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10